Articles

Find an Article

Filter articles

Applied Filters

Showing 91 to 100 of 279 results

LSIPR 50 2017: Yoshinori Ohsumi

Japan10-11-2017

Yoshinori Ohsumi was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.

LSIPR 50 2017: Michael Salzmann

Switzerland10-11-2017

Michael Salzmann was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.

LSIPR 50 2017: David Tomko

International10-11-2017

David Tomko was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.

LSIPR 50 2017: Marcus Dalton

EU10-11-2017

Marcus Dalton was selected in the LSIPR 50 2017 publication for​ ​his influence on the life sciences industry. He featured in the legal section, as LSIPR reports.

LSIPR 50 2017: Steve Bossone

US10-11-2017

Steve Bossone was selected in the LSIPR 50 2017 publication for​ ​his influence on the life sciences industry. He featured in the legal section, as LSIPR reports.

LSIPR 50 2017: Andrea Borucki

US10-11-2017

Andrea Borucki was selected in the LSIPR 50 2017 publication for​ ​her influence on the life sciences industry. She featured in the legal section, as LSIPR reports.

LSIPR 50 2017: Eduardo Andretto

Brazil10-11-2017

Eduardo Andretto was selected in the LSIPR 50 2017 publication for​ ​his influence on the life sciences industry. He featured in the legal section, as LSIPR reports.

Case report: diagnostics in Germany

Germany09-11-2017Joachim Wachenfeld

In September 2016, the German Federal Supreme Court decided a patent case that could have a major impact on companies working in the diagnostics field. Joachim Wachenfeld of Vossius & Partner reports.

The road ahead: potential challenges facing CRISPR/Cas patents

US09-11-2017Patricia Carson and Ashley Ross

Past successes by trailblazers in other biotechnological fields could assist potential patentees navigate legal bumps along the road to IP protection for CRISPR-related inventions, as Patricia Carson and Ashley Ross of Kirkland & Ellis describe.

Aslan: fighting cancer head-on

Singapore01-11-2017

Based in Singapore, biotech company Aslan Pharmaceuticals specialises in developing new treatments to fight cancers that are prevalent in Asia, often requiring licensing deals to ensure it is fully equipped. LSIPR spoke to general counsel Ben Goodger to find out more.

Showing 91 to 100 of 279 results

LSIPR